Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRILOGY ACS
2007-005210-39Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acute coronary syndrome (ACS), unstable angina and Non-ST-segment elevation myocardial infarction (NSTEMI) comparing Prasugrel + aspirin with Clopidogrel + aspirin (2 arms). Primary endpoint: Primary efficacy measure. Started Mar 2008; status: completed.
02
Drugs
prasugrelclopidogrelaspirin
03
Conditions
acute coronary syndrome (ACS)unstable anginaNon-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on 2007-005210-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005210-39.